PERLMUTTER ROGER M — SEC Form 4 filings

SEC reporting owner CIK 1184228. 3 Form 4 filings on record with FilingPulse; latest filed 2026-03-04.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2024-04-08 to 2026-03-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Eikon Therapeutics, Inc. (EIKN)See remarks, Director24
NGM BIOPHARMACEUTICALS INC (NGM)Director13

Form 4 filings — PERLMUTTER ROGER M

FiledFormIssuerReported transactionsSource
2026-03-044Eikon Therapeutics, Inc. (EIKN)Grant/award (A): 268,176 (derivative) @ $0EDGAR
2026-02-104Eikon Therapeutics, Inc. (EIKN)Conversion (C): 284,857 · Conversion (C): 1,268,891 (derivative) · Conversion (C): 855,512 (derivative)EDGAR
2024-04-084NGM BIOPHARMACEUTICALS INC (NGM)Disposition to issuer (D): 78,407 (derivative) · Disposition to issuer (D): 24,222 (derivative) · Disposition to issuer (D): 46,238 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1184228 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →